NCT03782857

Brief Summary

The study evaluates the effect of early follow up in a preventive clinic with stepwise treatment of high blood pressure and lowering blood cholesterol. Half the participants were randomized to the preventive clinic group and the other half to control group with the usual treatment: one visit to the outpatient clinic three months after discharge with a diagnosis of stroke or transient ischemic attack (TIA)

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
78

participants targeted

Target at P50-P75 for not_applicable stroke

Timeline
Completed

Started Jun 2012

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 26, 2012

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 17, 2013

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 17, 2013

Completed
5 years until next milestone

First Submitted

Initial submission to the registry

December 19, 2018

Completed
1 day until next milestone

First Posted

Study publicly available on registry

December 20, 2018

Completed
Last Updated

December 21, 2018

Status Verified

December 1, 2018

Enrollment Period

1.5 years

First QC Date

December 19, 2018

Last Update Submit

December 20, 2018

Conditions

Outcome Measures

Primary Outcomes (1)

  • Blood pressure treated to target

    The investigator used individual targets of blood pressure: In case of hemorrhagic stroke: BP\<130/80 mm Hg, in case of ischemic heart disease: BP target according to stroke diagnosis, but no lower than 130/80 mm Hg, in case of diabetes or chronic kidney disease: BP\<130/80 mm Hg, age\>80 years: \<150/90 mm Hg, others: \<140/90 mm Hg

    At follow up 10 months after inclusion in the study

Secondary Outcomes (1)

  • Reduction in blood pressure

    At follow up 10 months after inclusion in the study

Other Outcomes (6)

  • Reduction in LDL-cholesterol

    At follow up 10 months after inclusion in the study

  • LDL-cholesterol treated to target

    At follow up 10 months after inclusion in the study

  • Intensification of preventive treatment

    From discharge from the stroke unit to final follow up in study

  • +3 more other outcomes

Study Arms (2)

Intervention group

EXPERIMENTAL

Initiation/stepwise escalation of antihypertensive medication in case of blood pressure above individual target Initiation/stepwise escalation of cholesterol lowering medication in case of LDL-cholesterol above individual target Advice on healthy lifestyle and life long adherence to preventive medication

Behavioral: Intervention

Control group

NO INTERVENTION

Participants had the usual treatment: all patients were invited to one visit in the outpatient clinic three months after discharge with a diagnosis of stroke/TIA

Interventions

InterventionBEHAVIORAL

Prevention of recurrent stroke, myocardial infarction and death Stepwise escalation of preventive medication Life style counselling including adherence to preventive treatment

Intervention group

Eligibility Criteria

Age19 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Stroke

Interventions

Methods

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Intervention Hierarchy (Ancestors)

Investigative Techniques

Study Officials

  • Nete Hornnes, MPH,Ph.d

    Department of Neurology, Herlev Hospital, 2730 Herlev, Denmark

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: Participants were randomized 1:1 to intervention or control group
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Research Nurse

Study Record Dates

First Submitted

December 19, 2018

First Posted

December 20, 2018

Study Start

June 26, 2012

Primary Completion

December 17, 2013

Study Completion

December 17, 2013

Last Updated

December 21, 2018

Record last verified: 2018-12

Data Sharing

IPD Sharing
Will not share